[Development of the novel delivery system of GLP-1 administration for the treatment of diabetes mellitus].

Abstract

Glucagon-like peptide 1 (GLP-1) is a peptide produced in the endocrine L cells of the distal intestine. GLP-1(7-36)NH2 is a major molecular form that stimulates insulin release, reduces food intake, and has a potential to promote beta-cell regeneration. We have developed a device for intranasal application of GLP-1(7-36)NH2 and completed a double-blind… (More)

Topics

Cite this paper

@article{Nakazato2011DevelopmentOT, title={[Development of the novel delivery system of GLP-1 administration for the treatment of diabetes mellitus].}, author={Masamitsu Nakazato}, journal={Nihon rinsho. Japanese journal of clinical medicine}, year={2011}, volume={69 5}, pages={918-22} }